These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11035616)

  • 1. Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team.
    Koblin BA; Holte S; Lenderking B; Heagerty P
    J Acquir Immune Defic Syndr; 2000 Aug; 24(5):451-7. PubMed ID: 11035616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States.
    Koblin BA; Heagerty P; Sheon A; Buchbinder S; Celum C; Douglas JM; Gross M; Marmor M; Mayer K; Metzger D; Seage G
    AIDS; 1998 May; 12(7):785-93. PubMed ID: 9619811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya.
    Mutisya EM; Mutua G; Nyasani D; Nduta H; Kabuti RW; Muturi-Kioi V; Omosa-Manyonyi G; Abaasa A; Lindan K; Price MA; Kimani J; Anzala AO
    PLoS One; 2020; 15(8):e0238028. PubMed ID: 32834018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study.
    Capitine IPU; Macicame IB; Uanela AM; Bhatt NB; Yates A; Milazzo M; Nwoga C; Crowell TA; Michael NL; Robb ML; Jani IV; Kroidl A; Polyak CS; De Schacht C;
    PLoS One; 2021; 16(12):e0260126. PubMed ID: 34855790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain.
    Etcheverry MF; de Lazzari E; Fuchs JD; Meroño M; Sierra E; Del Romero J; Evans JL; Mendez-Arancibia E; Jacques C; Rojas D; Segú M; Gatell JM; Joseph J
    AIDS Behav; 2010 Jun; 14(3):607-17. PubMed ID: 19037720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military.
    McGrath JW; George K; Svilar G; Ihler E; Mafigiri D; Kabugo M; Mugisha E
    J Acquir Immune Defic Syndr; 2001 Aug; 27(4):381-8. PubMed ID: 11468427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia.
    Van de Ven P; Mao L; Crawford J; Prestage G; Grulich A; Kaldor J; Kippax S
    Int J STD AIDS; 2005 Apr; 16(4):314-7. PubMed ID: 15899086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men.
    Li Q; Luo F; Zhou Z; Li S; Liu Y; Li D; Shi W; Raymond HF; Ruan Y; Shao Y
    Vaccine; 2010 Jun; 28(29):4638-43. PubMed ID: 20452428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda.
    Kiwanuka N; Robb M; Kigozi G; Birx D; Philips J; Wabwire-Mangen F; Wawer MJ; Nalugoda F; Sewankambo NK; Serwadda D; Gray RH
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):721-5. PubMed ID: 15167291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.
    Connochie D; Tingler RC; Bauermeister JA
    Vaccine; 2019 Oct; 37(43):6494-6499. PubMed ID: 31522806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.
    Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR
    BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India: a social ecological approach.
    Chakrapani V; Newman PA; Singhal N; Jerajani J; Shunmugam M
    PLoS One; 2012; 7(12):e51080. PubMed ID: 23226560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users.
    Dhalla S; Poole G; Singer J; Patrick DM; Wood E; Kerr T
    Vaccine; 2010 Feb; 28(7):1663-7. PubMed ID: 20044049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of HIV vaccine trial participation: an Indian perspective.
    Sahay S; Mehendale S; Sane S; Brahme R; Brown A; Charron K; Beyrer C; Bollinger R; Paranjape R
    Vaccine; 2005 Feb; 23(11):1351-8. PubMed ID: 15661383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to participate in HIV vaccine research in a peri-urban South African community.
    Smit J; Middelkoop K; Myer L; Seedat S; Bekker LG; Stein DJ
    Int J STD AIDS; 2006 Mar; 17(3):176-9. PubMed ID: 16510005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda.
    Ruzagira E; Wandiembe S; Bufumbo L; Levin J; Price MA; Grosskurth H; Kamali A
    Trop Med Int Health; 2009 Feb; 14(2):196-203. PubMed ID: 19207177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment using respondent driven sampling, risk behaviors assessment and willingness of young female sex workers (18-25 years) in Dar Es Salaam, Tanzania to participate in HIV vaccine trials.
    Mbunda T; Tarimo EAM; Bakari M; Sandström E; Kulane A
    BMC Public Health; 2019 Nov; 19(1):1537. PubMed ID: 31796002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials.
    Hays RB; Kegeles SM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):164-71. PubMed ID: 10048904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US.
    Priddy FH; Cheng AC; Salazar LF; Frew PM
    Int J STD AIDS; 2006 Feb; 17(2):99-102. PubMed ID: 16464270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.